Foghorn Therapeutics vs Tango Therapeutics
FHTX and TNGX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FHTX and TNGX compare
Tango Therapeutics is the larger company, worth 34 times as much as Foghorn Therapeutics ($3.7B against $109M).
Tango Therapeutics grew revenue faster over the last twelve months (121% versus 52.0% for Foghorn Therapeutics).
Foghorn Therapeutics keeps more of each dollar of sales as profit, with a net margin of −176% compared with −230% at Tango Therapeutics.
Tango Therapeutics scores higher on the StockData Score (10 against 9 for Foghorn Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FHTX | TNGX |
|---|---|---|
| Size and price | ||
| Market cap | $109M | $3.7B |
| Share price | $1.83 | $22.11 |
| Change, 1 year | −61.0% | 171% |
| Change, 5 years | −86.6% | 114% |
| Beta (5Y) | 2.82 | 1.67 |
| Employees | 106 | 137 |
| StockData Score | ||
| Total score | 9 | 10 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 1 | 2 (better) |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 3.0× (better) | 69.3× |
| P/B | – | 3.6× |
| FCF yield | −77.6% | −3.9% (better) |
| Fair value | – | $9.71 |
| Margin of safety | – | −128% |
| Growth | ||
| Revenue growth (TTM) | 52.0% | 121% (better) |
| Revenue growth, 5Y average | 135% (better) | 52.1% |
| Profitability | ||
| Operating margin | −198% (better) | −253% |
| Net margin | −176% (better) | −230% |
| FCF margin | −229% (better) | −268% |
| Return on equity | – | −21.3% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 3.36 | 50.82 (better) |
| Altman Z-score | −4.61 | 45.17 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 75.6% | 127% |
| Held by insiders | 36.3% | 11.7% |
| Insider net buying, 12 months | – | −$8.1M |
| Short interest, % of float | 6.0% | 32.4% |
Go deeper
- FHTX stock overview
- FHTX income statement
- FHTX valuation and score
- TNGX stock overview
- TNGX income statement
- TNGX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.